Israel Englander Bluejay Diagnostics, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
About Bluejay Diagnostics, Inc.
- Ticker BJDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,152,300
- Market Cap $72.1M
- Description
- Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoass...